Important Changes in Diabetes Treatment in Poland: Decision Pending at Ministry of Health

Rzeczpospolita is closely monitoring a potentially groundbreaking development in diabetes care within Poland. The prospect of expanding insulin pump reimbursement to include patients over 26 years old represents a significant step towards more equitable and effective treatment for a growing number of Poles living with diabetes.

“

Czekamy na podpis ministry zdrowia pod rozporządzeniem

For years, the medical community and patient advocacy groups have highlighted the disparity in access to insulin pumps. The current system, which limits subsidized access to those under 26, places a substantial financial burden on individuals who develop diabetes later in life or who exceed the age limit. The cost of these devices, often tens of thousands of zlotys, is prohibitive for many, forcing them onto less effective or less convenient treatment methods.

The recent positive recommendation from the Agency for Health Technology Assessment and Tarification (AOTMiT) is a cause for optimism. This recommendation, based on renewed analysis, suggests that the agency recognizes the clinical benefits and cost-effectiveness of insulin pumps for a wider patient demographic. The Federation of Diabetics, represented by Dr. Monika Zamarlik, has been a vocal proponent of this change, emphasizing that the annual cost to the state, estimated at up to 36 million PLN, is a relatively small investment when weighed against the potential to prevent serious complications and improve patients' quality of life.

“

Roczne koszty tej refundacji wyniosłyby do 36 mln zł, co w skali kraju nie jest wielką kwotą.

As a Polish publication, Rzeczpospolita understands the deep personal and societal impact of chronic diseases like diabetes. This potential policy shift is not merely about medical technology; it's about ensuring that all Polish citizens, regardless of age, have access to the best available treatments. We await the Health Minister's final decision with anticipation, hopeful that this long-awaited change will soon become a reality, bringing much-needed relief and improved health outcomes to thousands of our fellow citizens.

“

Gdy pacjent kończy 26 lat i traci refundację, często nie stać go na zakup własnej pompy. W efekcie zaczyna mieć znacznie gorsze wyniki.